Skip to main content
. Author manuscript; available in PMC: 2012 Nov 7.
Published in final edited form as: Mol Imaging. 2012 Jun;11(3):177–186.

Figure 4.

Figure 4

a. Intensity distribution after injecting Angiosense through the tail vein before, and 12h and 7d after the course of treatment.

b. Correlation between Affibody- Alexa Fluor conjugate and AngioSence in tumor area after subtracting contralateral side at 3h after injecting through tail vein.